Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722912
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2023-02-10
First Post:
2022-10-04
Brief Title:
Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Organization Data
Organization:
Incyte Corporation
Class:
INDUSTRY
Study ID:
I 18424-22-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Incyte Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None